Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
Download Biotech Empire full books in PDF, epub, and Kindle. Read online Biotech Empire ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author : Andrew Bosworth
Publisher :
ISBN 13 : 9781606434536
Total Pages : 0 pages
Book Rating : 4.4/5 (345 download)
Download or read book Biotech Empire written by Andrew Bosworth and published by . This book was released on 2008 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Author : Jeremy Rifkin
Publisher : Penguin
ISBN 13 : 0874779537
Total Pages : 289 pages
Book Rating : 4.8/5 (747 download)
Download or read book The Biotech Century written by Jeremy Rifkin and published by Penguin. This book was released on 1999-04-05 with total page 289 pages. Available in PDF, EPUB and Kindle. Book excerpt: In this seminal book, Jeremy Rifkin explores the epic marriage between computer technology and genetic engineering, and the historic transition into the Age of Biotechnology. Already, Rifkin explains, our economy is undergoing a massive shift away from the Industrial Age and into an era in which giant life-science corporations are fashioning a bioindustrial world.Humanity is on the brink of wielding greater control over the shape of life--how we are born; how our food supply is created; the traits our children may have--than has ever been imagined. But with each step into this new era, we must ask ourselves: At what cost?
Author : Donald L. Drakeman
Publisher : Oxford University Press
ISBN 13 : 0195084004
Total Pages : 241 pages
Book Rating : 4.1/5 (95 download)
Download or read book From Breakthrough to Blockbuster written by Donald L. Drakeman and published by Oxford University Press. This book was released on 2022 with total page 241 pages. Available in PDF, EPUB and Kindle. Book excerpt: "Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--
Author : Melinda E. Cooper
Publisher : University of Washington Press
ISBN 13 : 0295990317
Total Pages : 233 pages
Book Rating : 4.2/5 (959 download)
Download or read book Life as Surplus written by Melinda E. Cooper and published by University of Washington Press. This book was released on 2011-02-01 with total page 233 pages. Available in PDF, EPUB and Kindle. Book excerpt: Focusing on the period between the 1970s and the present, Life as Surplus is a pointed and important study of the relationship between politics, economics, science, and cultural values in the United States today. Melinda Cooper demonstrates that the history of biotechnology cannot be understood without taking into account the simultaneous rise of neoliberalism as a political force and an economic policy. From the development of recombinant DNA technology in the 1970s to the second Bush administration's policies on stem cell research, Cooper connects the utopian polemic of free-market capitalism with growing internal contradictions of the commercialized life sciences. The biotech revolution relocated economic production at the genetic, microbial, and cellular level. Taking as her point of departure the assumption that life has been drawn into the circuits of value creation, Cooper underscores the relations between scientific, economic, political, and social practices. In penetrating analyses of Reagan-era science policy, the militarization of the life sciences, HIV politics, pharmaceutical imperialism, tissue engineering, stem cell science, and the pro-life movement, the author examines the speculative impulses that have animated the growth of the bioeconomy. At the very core of the new post-industrial economy is the transformation of biological life into surplus value. Life as Surplus offers a clear assessment of both the transformative, therapeutic dimensions of the contemporary life sciences and the violence, obligation, and debt servitude crystallizing around the emerging bioeconomy.
Author : Francoise Simon
Publisher : John Wiley & Sons
ISBN 13 : 1119216176
Total Pages : 322 pages
Book Rating : 4.1/5 (192 download)
Download or read book Managing Biotechnology written by Francoise Simon and published by John Wiley & Sons. This book was released on 2017-10-16 with total page 322 pages. Available in PDF, EPUB and Kindle. Book excerpt: A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE “Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they can–and must–apply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system.” BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM “Simon and Giovannetti have written an essential user’s manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds.” EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB “If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about.” JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS “Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to today’s innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book.”
Author : Sally Smith Hughes
Publisher : University of Chicago Press
ISBN 13 : 0226359204
Total Pages : 231 pages
Book Rating : 4.2/5 (263 download)
Download or read book Genentech written by Sally Smith Hughes and published by University of Chicago Press. This book was released on 2011-09-21 with total page 231 pages. Available in PDF, EPUB and Kindle. Book excerpt: In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech’s improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech’s science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech’s founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. Integrating the scientific, the corporate, the contextual, and the personal, Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.
Author : Daniel Charles
Publisher : Perseus Books Group
ISBN 13 : 9780738202914
Total Pages : 390 pages
Book Rating : 4.2/5 (29 download)
Download or read book Lords of the Harvest written by Daniel Charles and published by Perseus Books Group. This book was released on 2001-09-10 with total page 390 pages. Available in PDF, EPUB and Kindle. Book excerpt: The controversy over genetically engineered foods is chronicled in a study that takes readers deep into the heart of the new biotech food empire.
Author : Ronald P. Evens
Publisher : CRC Press
ISBN 13 : 0429678681
Total Pages : 182 pages
Book Rating : 4.4/5 (296 download)
Download or read book Biotechnology written by Ronald P. Evens and published by CRC Press. This book was released on 2020-06-04 with total page 182 pages. Available in PDF, EPUB and Kindle. Book excerpt: The over-riding premise for biotechnology in this book is bringing novel products to market to substantially advance patient care and disease mitigation. Biotechnology, over its relatively brief existence of 40 years, has experienced a mercurial growth. The vast educational need for biotechnology information in this rapidly burgeoning field is a basic rationale here. However a more prominent underpinning is that, bringing biotech products to market for patient care involves success in the following four areas of engagement simultaneously - scientific advances for healthcare technologies, novel and varied products for untreated diseases, regulatory authorities, and biotech companies. Features Comprehensive coverage of biotechnology science topics used in development and manufacturing Addresses all the scientific technologies within biotechnology responsible for products on the market and the pipeline Presents business issues such as marketing and sales of the products, as well as companies engaged, and how biotech business has evolved
Author : Bryan Bergeron
Publisher : John Wiley & Sons
ISBN 13 : 0471647578
Total Pages : 384 pages
Book Rating : 4.4/5 (716 download)
Download or read book Biotech Industry written by Bryan Bergeron and published by John Wiley & Sons. This book was released on 2004-04-12 with total page 384 pages. Available in PDF, EPUB and Kindle. Book excerpt: "The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks. Bergeron and Chan do a remarkable job of providing a sweeping insightful, and probing assessment of the current state and likely evolution of this global industry. This book is essential reading for the executive who desires a thorough understanding of this business and its potential."--John P. Glasser, Vice President and Chief Information Offers, Partners Healthcare System, Inc. "Bergeron and Chan have done a marvelous job integrating many different perspectives to give the reader a coherent road map of the biotech industry for the next decade. This powerful book is anchored by numerous relevant examples that create a framework which any life sciences professional needs to understand. Of particular note is the compelling assessment of the IT industry and its impact on the life sciences as these industries converge."--Michael A. Greeley, Managing General Partner, IDG Ventures. An in-depth examination of the growth and financing of the biotechnology industry worldwide Biotech Industry: A Global, Economic, and Financing Overview provides a thorough look at the current state of the biotechnology industry, including where major research is being conducted, where it's being applied, and where money and intellectual capital are flowing. Written by a renowned business columnist and an entrepreneurial scientist in the biotech area, this unique book gives Eos and other senior-level managers an understanding of Asia's pivotal role in the worldwide success of biotechnology commercialization, as well as insight into the biotech market over the next decade.
Author : Craig D. Shimasaki
Publisher : Springer Science & Business Media
ISBN 13 : 1441900640
Total Pages : 282 pages
Book Rating : 4.4/5 (419 download)
Download or read book The Business of Bioscience written by Craig D. Shimasaki and published by Springer Science & Business Media. This book was released on 2009-09-18 with total page 282 pages. Available in PDF, EPUB and Kindle. Book excerpt: My journey into this fascinating field of biotechnology started about 26 years ago at a small biotechnology company in South San Francisco called Genentech. I was very fortunate to work for the company that begat the biotech industry during its formative years. This experience established a solid foundation from which I could grow in both the science and business of biotechnology. After my fourth year of working on Oyster Point Boulevard, a close friend and colleague left Genentech to join a start-up biotechnology company. Later, he approached me to leave and join him in of all places – Oklahoma. He persisted for at least a year before I seriously considered his proposal. After listening to their plans, the opportunity suddenly became more and more intriguing. Finally, I took the plunge and joined this ent- preneurial team in cofounding and growing a start-up biotechnology company. Making that fateful decision to leave the security of a larger company was extremely difficult, but it turned out to be the beginning of an entrepreneurial career that forever changed how I viewed the biotechnology industry. Since that time, I have been fortunate to have cofounded two other biotechnology com- nies and even participated in taking one of them public. During my career in these start-ups, I held a variety of positions, from directing the science, operations, regulatory, and marketing components, to subsequently becoming CEO.
Author : Tom Abate
Publisher : Macmillan
ISBN 13 : 9780805075083
Total Pages : 308 pages
Book Rating : 4.0/5 (75 download)
Download or read book The Biotech Investor written by Tom Abate and published by Macmillan. This book was released on 2004 with total page 308 pages. Available in PDF, EPUB and Kindle. Book excerpt: The world is entering a biotechnology boom -- but only informed investors will prosper in the extremely complex biotech business. In The Biotech Investor, Tom Abate separates the bioengineered wheat from the chaff, offering the definitive guide to the science, finances, time horizon, and commercial potential of this burgeoning industry. Abate, a technology reporter for the San Francisco Chronicle, provides guidelines or assessing company leadership, easy-to-digest reports from the labs, and indispens-able investor tools and metrics.
Author : Cynthia Robbins-roth
Publisher : Perseus Books
ISBN 13 :
Total Pages : 280 pages
Book Rating : 4.F/5 ( download)
Download or read book From Alchemy To Ipo written by Cynthia Robbins-roth and published by Perseus Books. This book was released on 2000-05-18 with total page 280 pages. Available in PDF, EPUB and Kindle. Book excerpt: A fascinating glimpse inside the life-and-death business of biotechnology.
Author : Craig Shimasaki
Publisher : Academic Press
ISBN 13 : 0128155868
Total Pages : 684 pages
Book Rating : 4.1/5 (281 download)
Download or read book Biotechnology Entrepreneurship written by Craig Shimasaki and published by Academic Press. This book was released on 2020-05-16 with total page 684 pages. Available in PDF, EPUB and Kindle. Book excerpt: This second edition of Biotechnology Entrepreneurship: Leading, Managing, and Commercializing Innovative Technologies is an authoritative, easy-to-read guide covering biotechnology entrepreneurship and the process of commercializing innovative biotechnology products. This best practice resource is for professional training programs, individuals starting a biotech venture, and for managers and experienced practitioners leading biotech enterprises. It is a valuable resource for those working at any level in the biotech industry, and for professionals who support and provide essential resources and services to the biotech industry. This practical, “how-to book is written by seasoned veterans experienced in each of the operational functions essential for starting, managing, and leading a successful biotech company.Biotechnology Entrepreneurship explains the biotech business components and underlying strategies, interspersed with practical lessons from successful biotech entrepreneurs, educators, and experienced practitioners. These veteran contributors share their insights on how to be successful in this challenging but exciting industry. Subjects range from technology licensing and translating an idea into a viable business, forming your legal company entity, securing angel and venture capital, navigating product development, FDA regulatory approval, and biomanufacturing.This book is a user-friendly guide to decision-making and overall strategy written as a hands-on management tool for leaders and managers of these dynamic biotechnology ventures. If you are contemplating starting a biotech company, are a manager at any level, a seasoned veteran, or service provider in the biotech industry, this book is a “must read. This second edition includes several new chapters on topics such as: What you need to know about valuation and term sheets Investor presentations and what you need in a biotech investor pitch deck Mentorship and why you need mentors Artificial intelligence applications in biotech and pharma Common biotech entrepreneur mistakes and how to avoid them
Author : Jim Mellon
Publisher : John Wiley & Sons
ISBN 13 : 1119963184
Total Pages : 363 pages
Book Rating : 4.1/5 (199 download)
Download or read book Cracking the Code written by Jim Mellon and published by John Wiley & Sons. This book was released on 2012-05-14 with total page 363 pages. Available in PDF, EPUB and Kindle. Book excerpt: Everything you need to know about the most important trend in the history of the world Within most people's lifetimes, the developments in the biotechnology sector will allow us to live increasingly long and healthy lives, as well as provide us with technological innovations that will transform the way we live. But these innovations offer more than just hope for a better life, but hope for better returns too. Financial returns of incredible magnitude await savvy investors and businesspeople who can see the massive changes on the horizon. This book details these fast-moving trends and innovations and offers extensive advice on how to profit from them in business and investing.
Author : Scott Dessain
Publisher : Academic Press
ISBN 13 : 0128092092
Total Pages : 277 pages
Book Rating : 4.1/5 (28 download)
Download or read book Preserving the Promise written by Scott Dessain and published by Academic Press. This book was released on 2016-10-05 with total page 277 pages. Available in PDF, EPUB and Kindle. Book excerpt: Preserving the Promise: Improving the Culture of Biotech Investment critically examines why most biotech startups fail, as they emerge from universities into an ecosystem that inhibits rather than encourages innovation. This "Valley of Death" squanders our public investments in medical research and with them, the promise of longer and healthier lives. The authors explicate the Translation Gap faced by early stage biotech companies, the result of problematic technology transfer and investment practices, and provide specific prescriptions for improving translation of important discoveries into safe and effective therapies. In Preserving the Promise, Dessain and Fishman build on their collective experience as company founders, healthcare investor (Fishman) and physician/scientist (Dessain). The book offers a forward-looking, critical analysis of "conventional wisdom" that encumbers commercialization practices. It exposes the self-defeating habits of drug development in the Valley of Death, that waste money and extinguish innovative technologies through distorted financial incentives. Explains why translation of biotech discovery into medicine succeeds so infrequently that it’s been dubbed the Valley of Death Uncovers specific decision-making strategies that more effectively align incentives, improving clinical and financial outcomes for investors, inventor/entrepreneurs, and patients Examines the critical, early stages of commercialization, where technology transfer offices and Angels act as gatekeepers to development, and where tension between short-term financial and long-term clinical aspirations sinks important technologies Deconstructs the forces driving biotech, recasts them in a proven conceptual framework, and offers practical guidance for making the system better
Author : Jeffrey St. Clair
Publisher : AK Press
ISBN 13 : 1849351112
Total Pages : 320 pages
Book Rating : 4.8/5 (493 download)
Download or read book Hopeless written by Jeffrey St. Clair and published by AK Press. This book was released on 2012-05-15 with total page 320 pages. Available in PDF, EPUB and Kindle. Book excerpt: "Those who feel that like lemmings they are being led over a cliff would be well-advised not to read this book. They may discover that they are right."—Noam Chomsky “Jeffrey St. Clair and Joshua Frank have skillfully smoked out the real Barack Obama . . . the technofascist military strategist disguised as a Nobel Peace Laureate, but owned, operated, and controlled by Wall Street, Corporate America, and the Pentagon.”—Thomas H. Naylor, co-author of Affluenza, Downsizing the USA “The writers assembled here hit hard, with accuracy, and do not pull punches."—Marcus Rediker, author of The Slave Ship: A Human History The Barack Obama revolution was over before it started, guttered by the politician’s overweening desire to prove himself to the grandees of the establishment. From there on, other promises proved ever easier to break. Here's the book that dares not let Obama off the hook. It's all here: the compromises, the backstabbing, the same old imperial ambitions. Covering all major "Obummer" categories since he took office, this fast-paced collection will delight the critical and offer food for thought for those contemplating the 2012 electoral circus—and beyond. Jeffrey St. Clair is co-editor of CounterPunch, author of Born Under a Bad Sky and Been Brown So Long it Looked Green to Me, and co-author of Whiteout: The CIA, Drugs, and the Press. Joshua Frank is an environmental journalist and co-editor of Red State Rebels: Tales of Grassroots Resistance in the Heartland. His investigative reports and columns appear in CounterPunch, Chicago Sun-Times, Common Dreams, and AlterNet.
Author : Jon Paugh
Publisher :
ISBN 13 :
Total Pages : 112 pages
Book Rating : 4.X/5 (5 download)
Download or read book Meeting the Challenge written by Jon Paugh and published by . This book was released on 1997 with total page 112 pages. Available in PDF, EPUB and Kindle. Book excerpt:
